Suzhou Medsys Tech Co Ltd (603990) — Capital Reinvestment Ratio
Suzhou Medsys Tech Co Ltd (603990) has a Capital Reinvestment Ratio of 0.60x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.84 Million) in capital expenditures (CN¥10.62 Million). See Suzhou Medsys Tech Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suzhou Medsys Tech Co Ltd Capital Reinvestment Ratio (2012–2022)
This chart tracks Suzhou Medsys Tech Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check 603990 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd (2012–2022)
Year-by-year Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd from 2012 to 2022. For live market cap and broader valuation context, see Suzhou Medsys Tech Co Ltd (603990) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.49x | CN¥50.51 Million | CN¥24.58 Million | ▼ -57.2% |
| 2021 | 1.14x | CN¥36.04 Million | CN¥40.99 Million | ▲ +1187.4% |
| 2020 | 0.09x | CN¥100.48 Million | CN¥8.88 Million | ▼ -84.9% |
| 2019 | 0.58x | CN¥22.04 Million | CN¥12.89 Million | ▲ +71.3% |
| 2018 | 0.34x | CN¥48.67 Million | CN¥16.62 Million | ▼ -60.3% |
| 2016 | 0.86x | CN¥32.56 Million | CN¥28.01 Million | ▼ -59.6% |
| 2015 | 2.13x | CN¥37.54 Million | CN¥79.94 Million | ▲ +38.9% |
| 2014 | 1.53x | CN¥40.82 Million | CN¥62.59 Million | ▲ +139.5% |
| 2013 | 0.64x | CN¥32.84 Million | CN¥21.03 Million | ▲ +193.0% |
| 2012 | 0.22x | CN¥10.83 Million | CN¥2.37 Million | — |